Abstract 30 patients with homozygous β-thalassaemia aged 6 months to 7 years received
allogeneic marrow transplants following busulphan (Bu) and cyclophosphamide (Cy). Post …

A 16-month-old boy with thalassaemia major was prepared with one dose of dimethyl
busulphan, 5 mg/kg, and with cyclophosphamide, 50 mg/kg on 4 successive days, and given …

The safety and efficacy of a preparation with treosulfan/thiotepa/fludarabine were explored
in 20 thalassaemia patients given allogeneic marrow transplantation. Seventeen patients …

Bone marrow transplantation from an HLA-identical sibling can cure thalassaemia. The risk
of chemotherapy-induced sterility, however, represents a deterrent for many patients already …

Early trials of allogenic bone marrow transplantation (BMT) for homozygous β thalassemia
and the analyses of results of transplantation in patients under 17 years of age have allowed …

Since 1983, 350 patients aged 1 to 19 years with beta-homozygous thalassemia were given
infusions of HLA-identical marrow after high doses of busulphan and cyclophosphamide …

Abstract From August 1992 to August 1999, 44 patients received allogeneic haematopoietic
stem cell transplantation in a single institution. The donors were HLA-identical siblings …

In a study of the outcome of marrow transplantation in patients with advanced thalassemia,
40 patients with homozygous β-thalassemia who were 8 to 15 years of age (median, 10) …

Thirteen patients with homozygous beta thalassemia underwent allogeneic marrow
transplantation from sibling donors, 12 of whom were heterozygous for beta thalassemia. Six …

▪ Abstract Early trials of allogeneic bone marrow transplantation (BMT) for homozygous β-
thalassemia and the analyses of results of transplantation in patients less than 16 years old …